Doctor’s Life Simulator

Doctor's Life Simulator Chapter 359 Pfizer launches attack, Ming's Pharmaceutical Group is in crisis

Hearing what Director Huang said, the surrounding doctors were also shocked.

Qin Lang has actually reached the level of being able to produce textbooks, and he is also one of the top ten most difficult surgeries in surgery for heart transplantation.

"Director Qin, congratulations."

"Director Qin, it's amazing!"

In the department, all the doctors gathered around, congratulations and envy.

Qin Lang was not surprised by this. After all, when writing this expert report, he was mentally prepared.

However, Qin Lang was still very happy. After all, it was a supreme honor to be selected as a medical textbook in colleges and universities.

From then on, his name will be tied with the top and most senior professors and academicians, becoming one of the industry giants in the medical field.

At least, in the field of heart transplant surgery, Qin Lang is already a top expert in the country, and he can be regarded as a pioneer.

[Ding, new achievements, the compiled norms are selected into college textbooks, reward life simulation points: 3 points. 】

...

...

In the next few days, Qin Lang entered his daily life again.

During the week, I will spend three days in Hangzhou. In addition to the study of cardiovascular medicine, it is to control the progress of new drug research and development. With the conscientious efforts of Wang Rou's team, the research and development of smoking cessation drugs is steadily advancing.

In the remaining few days, Qin Lang will return to the first city hospital. Now Qin Lang's prestige and status have been further improved with the selection of college textbooks.

In the city's first hospital, Qin Lang's actions are more free. Emergency department, cardiology department, burn department, general surgery department, and several departments will be on duty in turn, and will be invited to give guidance if necessary.

After Qin Lang entered the normal rhythm of life, Ming's Pharmaceutical Group in Hangzhou is beaming from employees to the board of directors these days.

The entire company's stock price soared because of Qin Lang's stunning performance at the Huaguo Heart Conference and the progress of blockbuster new drugs at the press conference.

Taking this opportunity, Chairman Ming also increased his investment. For the new drug research and development trials in cooperation with the First Affiliated Hospital of Zijingang University, he made an additional investment and purchased more top-level equipment in the world.

In my own group, it is also through this Dongfeng and the success of recent days, desperately entering a new round of research and development of smoking cessation drugs.

"Above the Sky"

In the board of directors, some people expressed their negative opinions on Ming Dong's desperate behavior. They felt that such investment would be a major blow to the group in case the research and development of smoking cessation drugs fails.

However, Chairman Ming is still ready to insist that one is this kind of nicotine-free smoking cessation drug, which was first released in China and even in the world, and has a milestone significance. The second is that the domestic market for smoking cessation drugs is a blue ocean and worth exploring. Once successful, Mingshi Pharmaceutical Group will enter an explosive period with a bright future.

Although Ming's Pharmaceutical Group is a top pharmaceutical company in Zhejiang Province, it is basically generic drugs and agents, and does not have a core product of its own. Therefore, this time the world's first nicotine-free smoking cessation drug is also one of Ming Dong's Ideal and ambitious.

Under the insistence of Ming Dong, Ming's Pharmaceutical Group finally implemented this plan firmly and invested a lot of money into it.

...

...

Pfizer Zhejiang Office.

In the regional general manager's office, Wanfeng and his secretary had just finished a vigorous exercise and vented their stagnation in their hearts.

After all, Ming's Pharmaceutical Group was in the limelight during this time, the company's stock price soared, and the woman from Ming Dong was even more proud.

This made Wanfeng very unhappy.

Specially printed a picture of Dong Ming's head and put it on the secretary's face, Wanfeng had a storm.

A minute and a half later, Wanfeng walked out of the dark room of the office, and before he came to his desk, he clicked on an email.

After reading it, the whole person is ecstatic:

"The brand-new smoking cessation drug at the headquarters: tix, has successfully completed the Phase III clinical trial, and within a week, it will be able to obtain the approval and authorization of the FDA. When the new drug is launched on the day of the launch, I will take a look, you Mingshi What is the face of the pharmaceutical group?"

When Wanfeng thought about it, Dong Ming's desperate and depressed expression was a burst of excitement.

"In addition to the launch of the new drug, I also need to contact the Muddy Water Agency in the United States to provide various information about the Ming's Pharmaceutical Group and let them make a short report. ."

Wanfeng is an old fried dough stick with rich business skills.

As long as it is a means of attacking the opponent, he will use it.

In the next few days, Wanfeng devoted himself to intensive preparations, fighting a snake to beat seven inches. This time, he was confident that he would be able to hit the bottom of the Mingshi Pharmaceutical Group, and he would never be able to turn over again.

Wanfeng looked at the homepage of Ming's Pharmaceutical Group's official website and the latest information about their company, sneering again and again.

In particular, the largest picture is a new drug research and development laboratory project jointly organized by Ming's Pharmaceutical Group and the First Affiliated Hospital of Zijingang University.

Looking at the young doctor at the center of the picture, Wanfeng chuckled a few times:

"Do you really think that a new anti-tumor drug can be developed by such a young doctor? So far, the so-called completion of the first phase of clinical trials is still a long way to go."

Wanfeng was a little disgusted with Qin Lang, a young man. After all, it was this little doctor who repeatedly ruined his major affairs. The previous inbred mouse project made him lose face.

Recently, Ming's Pharmaceutical Group's popularity is infinite, and the source of it is also this hateful stinky boy.

"In the interview at the Heart Congress, he boldly proposed that a brand new drug to be launched in China is being developed, and it has entered the phase III clinical stage. Will it be available soon?"

Wanfeng sneered at this. Speaking of which, Pfizer's smoking cessation drug is about to be launched. If that little guy really has a new drug, Wanfeng also wants to fight with him and let him know, know, Pfizer The strength of the world's top pharmaceutical giant!

"Ming Dong, in a few days, I will step on you and crush you on the project that you value the most and put the most effort and energy into."

Thinking of this, Wanfeng pulled out his drawer again on a whim. There was a small electric bell in it, and he pressed it.

This bell is connected to the secretary's office next door.

After ringing the bell, Wanfeng entered the dark room behind the office after a while.

Another minute and a half later, Wanfeng walked out slightly tired.

half a month later.

Washington, USA, Pfizer Pharmaceutical Group, held a press conference. At the meeting, a new drug launched in the world, a brand-new nicotine-free smoking cessation drug: tix!

At the meeting, Pfizer comprehensively introduced this new drug, which is a new type of non-nicotine smoking cessation drug. The entire smoking cessation cycle is 12 weeks. The mechanism of action of this drug is different from traditional nicotine replacement therapy. Partial agonists of the body, which are structurally similar to nicotine, bind to nicotine receptors, and nerve cells release much less dopamine after binding.

It is a brand-new preparation with significant curative effect, curb smoking addiction and prevent relapse. It is divided into two dosage forms: 0.5mg and 1mg tablets. The recommended dosage of FDA is 2mg/d (1mg, 2 times/d).

For the birth of this new smoking cessation drug, the field of medicine is naturally a great shock.

Moreover, according to Pfizer's plan, in addition to Omi, it will also enter 15 countries including China, Singapore and Thailand.

This brand-new smoking cessation drug, after entering Huaguo, is named Changpei!

And after this brand-new smoking cessation drug came out, the entire Chinese medical circle was shocked.

All the Huaguo Pharmaceutical Groups sighed that Pfizer was the top in the industry, and it was also a pioneering new drug.

Zhejiang Province, Mingshi Pharmaceutical Group.

Jin Yaner was completely stunned. As Chairman Ming's secretary, she was of course very well informed about the news in the pharmaceutical industry.

For the first time, she watched the live video of Pfizer's press conference, and when she saw that Pfizer's new drug this time was a brand-new nicotine-free smoking cessation drug, Jin Yaner was shocked.

This is not an area where Ming's Pharmaceutical Group spent a lot of money and a lot of time in research and development. How could Pfizer launch this new drug before Ming's Pharmaceutical Group.

According to Pfizer's strength, this new drug will soon enter the Chinese market, which is a devastating blow to Ming's Pharmaceutical Group.

Jin Yaner walked into Chairman Ming's office a little lost.

Ming Dong was in a good mood recently because the company's stock price had soared. When he saw Jin Yaner coming in, he frowned with panic on his face.

"Xiaojin, what's the matter? The whole person is so panicked."

Dong Ming's tone was calm, he took a sip of the herbal tea and looked at his secretary.

"Ming Dong, there is very bad news. I also just learned... Pfizer Pharmaceuticals held a brand new new drug launch today and released a new drug..."

Jin Yaner didn't know how to tell Dong Ming about the bad news.

"Pfizer released a new drug? What new drug? Let me see."

Ming Dong has been busy with various matters of the company recently, so he did not take the time to understand Pfizer's press conference.

After all, now, all her energy and heart are spent on the research and development of Ming's Pharmaceutical Group's own new smoking cessation drug.

Jin Yaner hesitantly handed over the phone.

"Ming Dong, don't be too angry..."

Dong Ming took Jin Yan'er's phone and looked at it, then his face turned pale.

"How is it possible, how is it possible!"

Ming Dong's whole body suddenly lost more than half of her anger. After all, she invested all her human, material and financial resources in the research and development project of smoking cessation drugs this time.

However, the whole project is about to see hope. How could she have predicted that Pfizer Pharmaceuticals would take the lead.

"It has passed the full-stage clinical trial, and it has also been approved by the FDA in the United States. It will enter the Huaguo market soon, and even the Huaguo's trade name has been selected."

Ming Dong lost her mind for a while, which was a huge blow to her.

As the chairman of a group, under his own words, the projects he promoted have encountered unprecedented failures.

Of course, she was to blame. How agile Dong Ming's thinking was, he had already thought of a series of things that would be triggered because of this press conference.

"No, I need to convene a board of directors immediately to completely block the information about our company's desperate investment in the research and development of smoking cessation drugs."

Now Dong Ming can only break the wrist of a strong man, and immediately win the entire project of smoking cessation medicine.

All research and development stages are stopped and the loss is maximized. With the recent rise in the stock price of Ming's Pharmaceutical Group, as long as this major decision-making mistake is strangled within the group, the impact can still be controlled.

As long as you give some time, you can still control the influence to a minimum.

Ming Dong has already thought of a countermeasure, which is to simply put the company's next development direction into the projects in the field of new anti-tumor drugs and ventricular correction that cooperate with Qin Lang.

"Simply, in addition to the smoking cessation drug project, I also invested in the potential stock of Qinlang."

After Dong Ming had a plan, he asked Jin Yaner to convene all the board members immediately.

As a member of the board of directors of Mingshi Pharmaceutical Group, Qin Lang also received an invitation. However, Qin Lang was not very interested in the board meeting of Mingshi Pharmaceutical Group. At the same time, he had several operations on his hands, so he did not Not involved.

Under Ming's resolute action, the entire company's board of directors was summoned immediately.

It's just that when Dong Ming was preparing to block the news and turn the group's next development direction for the first time.

Wan Feng, the head of Pfizer Pharmaceuticals in Zhejiang Province, held a press conference before the board of directors of Ming Dong. The whole conference was prepared for half a month in advance. Naturally, it was fully and highly targeted!

Wanfeng first praised and promoted its own new drugs, and then exposed the smoking cessation drug project of Mingshi Pharmaceutical Group, which was recently fully devoted to research and development, and hit their guns!

Wanfeng also specially invited the manager of the American Muddy Waters Agency, Muddy Waters Company, which is a well-known short-selling agency in the world.

Before, Muddy Waters attacked a lot of Chinese stock companies, and even included some companies with good development in China.

In these short positions, the frequent successes have caused heavy losses to the enterprises of Huaguo.

Muddy Waters is very professional and cunning. It starts with some special events and attacks its opponents in all aspects, such as the business model, profitability, company value, company reputation, and investor confidence of the short-selling target.

Obviously, this time Ming's Pharmaceutical Group was completely manipulated by Muddy Waters. This time, the smoking cessation drug that Ming's Pharmaceutical Group devoted all its efforts to was hit by Pfizer and completely lost hope of turning over.

After all, everyone knows that in the same field, the same drug for smoking cessation, Pfizer's products, crush domestic pharmaceutical companies in an all-round way, not to mention that they are approved and certified by the US FDA.

Moreover, the most important thing is that Pfizer's new drugs have been fully launched and are about to enter the Huaguo market, while Ming's Pharmaceutical Group's new drugs have not even come out of the laboratory, and there is no clear launch node.

At the press conference, as soon as the report of the Muddy Waters Agency came out, the prospect of Ming's Pharmaceutical Group was instantly dimmed.

In addition to Ming's Pharmaceutical Group, Muddy Waters has conducted a comprehensive investigation into Qin Lang and Qin's Pharmaceutical Company, which were previously launched by Ming's Pharmaceutical Group.

For Qin's Pharmaceutical Company and Qin Lang's people, Muddy Water's evaluation is the packaged silver pewter tip.

Any new anti-tumor drug, or a new drug pioneered by Huaguo, is just a gimmick and a concept. It only exists in the PPT report~www.readwn.com~ It is impossible for it to be successfully launched in the short term.

In particular, the current management team of Qin's Pharmaceutical Company is still being formed, and the new general manager has just been dismissed by a pharmaceutical company in Zhejiang Province.

It has been less than a month since he took office, and the new management team has not been run in well. It is completely a temporary team and has no fighting power.

As for the research and development team, it is just an attending physician in the cancer prevention and treatment center of Zijingang University, led by a doctoral student.

The chairman of the pharmaceutical company, Qin Lang, is only a doctor in the First Affiliated Hospital of Zijingang University, and a master student at the First Affiliated Hospital of Zijingang University.

Do you still expect such a research and development team to come up with new drugs that can rival Pfizer? A fool's dream.

In the words of Muddy Waters, it is a packaged leather bag company that cannot be graceful.

How could such a temporary small company develop new anti-tumor drugs, and how could it be possible to develop mysterious new drugs that were first released in China?

As soon as the Muddy Waters report came out, coupled with the halo of Pfizer and the FDA, Ming's Pharmaceutical Group and Qin's Pharmaceutical Co., Ltd. were all caught in the ridicule of public opinion.

Even, there is no lack of malicious speculation, Qin Lang completely relied on Ming Dong's investment to build a laboratory building and deliver equipment to the First Affiliated Hospital of Zijingang University to obtain the position of laboratory leader.

Just a little white face who eats soft rice.

Ming's Pharmaceutical Group's board of directors is half open, and it can't go on.

On the same day, the share price of Mingshi Pharmaceutical Group fell by the limit! And that's just the beginning.

Ming's Pharmaceutical Group is caught in a huge crisis. +Bookmark+